ISW 2026 Puts Its Own Carbon Footprint on the Record
Focus Graphite Highlighted in Prime Minister Carney’s Historic Clean Energy and Critical Minerals Announcement; Completes Lac Knife Electrical Desktop Study
CITIC Resources’ 2026 Interim Net Profit Up 88.3%
Leading Across All Metrics: Xunce Technology Reports Record-High Mid-Year Revenue and Net Profit; AI-to-B Platform Enters a New Cycle of Exponential Growth
Chery Automobile Releases 2026 Interim Results: Dual-Engine Drive Solidifies Profitability, Globalization Unlocks Growth Space
– Approximately 3,000 participants enrolled with initial trial data expected in mid-2023 – SAN FRANCISCO,…
CAMBRIDGE, Mass., Dec. 21, 2022 (GLOBE NEWSWIRE) — Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader…
Ms. Yañez brings deep category experience and will lead Aerami’s focus on cardiopulmonary disease as…
– Conference call and webcast to be held on Monday, January 9, 2023 at 1:30…
Positive Results Spurs Launch of Akadeum’s Leukopak Isolation Kit citing speed, scalability, and cell recovery…
SEATTLE, Wash and VANCOUVER, British Columbia, Dec. 21, 2022 (GLOBE NEWSWIRE) — Achieve Life Sciences,…
Ji’an, Jiangxi, China, Dec. 21, 2022 (GLOBE NEWSWIRE) — Universe Pharmaceuticals INC (the “Company”) (Nasdaq:…
Pre-clinical tests show enhanced functionality of Pure-Vu EVS that can enable physicians to overcome common…
BALTIMORE, Dec. 21, 2022 (GLOBE NEWSWIRE) — Elixirgen Therapeutics, Inc., a clinical-stage biotechnology company focused…
DURHAM, N.C., Dec. 21, 2022 (GLOBE NEWSWIRE) — Novan, Inc. (“the Company” or “Novan”) (Nasdaq:…
AptameX™ Gen 2 Covid-19 rapid calibration outperforms Abbott Pan Bio and Clugene’s rapid tests in…
– Topline data expected to be announced in 2H 2023 – – Topline data from…
InflaRx will provide access to certain clinical, manufacturing and regulatory documentation for vilobelimab to facilitate…
MALVERN, Pa., Dec. 21, 2022 (GLOBE NEWSWIRE) — TELA Bio, Inc. (“TELA”), a commercial-stage medical…
RECONNECT initial screening visits are being adversely impacted by environmental factors, such as the “Tripledemic”…
Data demonstrate fosgonimeton enhances the HGF/MET system, promoting neuroprotective, neurotrophic and procognitive effects in multiple…
– The global THRIVE Phase 3 trial will be conducted in approximately 50 centers across…
Media Release COPENHAGEN, Denmark; December 21, 2022 JNDA submission supported by results of Japanese and…
Castellum, Inc. Provides Shareholders and Prospective Shareholders a Year-End Update Consistent with its requirements under…
First-in-human study aims to evaluate the safety and immunogenicity of prophylactic herpes virus vaccine candidate…